Literature DB >> 3076719

A two-year study of enteric infections associated with diarrhoeal diseases in children in urban Somalia.

M Casalino1, M W Yusuf, M Nicoletti, P Bazzicalupo, A Coppo, B Colonna, C Cappelli, C Bianchini, V Falbo, H J Ahmed.   

Abstract

A hospital-based systematic sample of 1667 children with severe diarrhoeal disease was studied in Mogadishu, Somalia, throughout 1983 and 1984. One or more enteric pathogens were found in 61% of the patients. Rotavirus (25%), enterotoxigenic Escherichia coli (11%), Shigella spp. (9%), Aeromonas hydrophila (9%), Giardia lamblia trophozoites (8%), Campylobacter jejuni (8%), and Vibrio cholerae non-O1 (6%) were the most frequently identified pathogens. Age-specific detection rates of enteric pathogens and helminths, seasonal patterns, and relationship of some specific infections with feeding status and main clinical features have been defined for all the sample examined.

Entities:  

Mesh:

Year:  1988        PMID: 3076719     DOI: 10.1016/0035-9203(88)90542-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  16 in total

Review 1.  Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization.

Authors:  N A Cunliffe; P E Kilgore; J S Bresee; A D Steele; N Luo; C A Hart; R I Glass
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

2.  Sources of microorganisms in pozol, a traditional Mexican fermented maize dough.

Authors:  C Wacher; A Cañas; P E Cook; E Barzana; J D Owens
Journal:  World J Microbiol Biotechnol       Date:  1993-03       Impact factor: 3.312

3.  Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo.

Authors:  A Fasano; F R Noriega; F M Liao; W Wang; M M Levine
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

4.  Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli.

Authors:  I R Henderson; J Czeczulin; C Eslava; F Noriega; J P Nataro
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  H-NS regulation of virulence gene expression in enteroinvasive Escherichia coli harboring the virulence plasmid integrated into the host chromosome.

Authors:  B Colonna; M Casalino; P A Fradiani; C Zagaglia; S Naitza; L Leoni; G Prosseda; A Coppo; P Ghelardini; M Nicoletti
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

6.  CadC is the preferential target of a convergent evolution driving enteroinvasive Escherichia coli toward a lysine decarboxylase-defective phenotype.

Authors:  Mariassunta Casalino; Maria Carmela Latella; Gianni Prosseda; Bianca Colonna
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

7.  Characterization of endemic Shigella flexneri strains in Somalia: antimicrobial resistance, plasmid profiles, and serotype correlation.

Authors:  M Casalino; M Nicoletti; A Salvia; B Colonna; C Pazzani; A Calconi; K A Mohamud; F Maimone
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Organization of aerobactin, hemolysin, and antibacterial resistance genes in lactose-negative Escherichia coli strains of serotype O4 isolated from children with diarrhea.

Authors:  B Colonna; L Ranucci; P A Fradiani; M Casalino; A Calconi; M Nicoletti
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

9.  Expression of the virulence plasmid-carried apyrase gene (apy) of enteroinvasive Escherichia coli and Shigella flexneri is under the control of H-NS and the VirF and VirB regulatory cascade.

Authors:  F Berlutti; M Casalino; C Zagaglia; P A Fradiani; P Visca; M Nicoletti
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 10.  Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005.

Authors:  P K Ram; J A Crump; S K Gupta; M A Miller; E D Mintz
Journal:  Epidemiol Infect       Date:  2007-08-09       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.